Diabetes, a chronic condition that affects millions of people, may have a connection with Alzheimer's disease. Unofficially ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Gum disease appears to disrupt brain activity, potentially increasing a person's risk of cognitive decline. People with gum ...

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

Gum disease appears to disrupt brain activity, potentially increasing a person’s risk of cognitive decline.People with ...

Electric toothbrushes can be especially helpful for older adults, as they are more effective at removing plaque and easier to ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Our medical tools and techniques are rapidly improving but our system for delivering health care is a source of widespread ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...

Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.